Invention Grant
- Patent Title: Anti-galectin-9 antibodies and uses thereof
-
Application No.: US17851947Application Date: 2022-06-28
-
Publication No.: US11629191B2Publication Date: 2023-04-18
- Inventor: Shohei Koide , George Miller , Akiko Koide , Linxiao Chen , Eric Elenko , Aleksandra Filipovic , Joseph Bolen
- Applicant: New York University , PureTech Health, LLC
- Applicant Address: US NY New York; US MA Boston
- Assignee: New York University,PureTech Health, LLC
- Current Assignee: New York University,PureTech Health, LLC
- Current Assignee Address: US NY New York; US MA Boston
- Agency: Hodgson Russ LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61P35/00 ; C07K16/06 ; A61P37/06
Abstract:
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9. Such anti-Galectin-9 antibodies may also be used to diagnose and/or to treat diseases associated with Galectin-9, such as autoimmune diseases and solid tumors.
Public/Granted literature
- US20220340666A1 ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF Public/Granted day:2022-10-27
Information query
